Page last updated: 2024-11-02

moxonidine and Diabetic Angiopathies

moxonidine has been researched along with Diabetic Angiopathies in 1 studies

moxonidine: structure given in first source

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research Excerpts

ExcerptRelevanceReference
"Subjects with type 2 diabetes experience an increased cardiovascular morbidity and mortality, related to a high prevalence of hypertension, dyslipidemia, and obesity."2.71Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes. ( Gödicke, J; Häring, HU; Helsberg, K; Jacob, S; Klimm, HJ; Rett, K, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacob, S1
Klimm, HJ1
Rett, K1
Helsberg, K1
Häring, HU1
Gödicke, J1

Trials

1 trial available for moxonidine and Diabetic Angiopathies

ArticleYear
Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2004, Volume: 112, Issue:6

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathi

2004